NYSE: KN

Knowles Corp

CIK 0001587523 · SIC 3651 · Household Audio & Video

Mid Revenue $593M Assets $1.1B as of Aug 24, 2026

Unless the context otherwise requires, references in this Annual Report on Form 10-K to “Knowles,” the “Company,” “we,” “our,” or “us” refer to Knowles Corporation and its consolidated subsidiaries. About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (FLO 10-Q) is open in full — no account needed.

10-Q Filed Jul 28, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jul 23, 2026 · Period ending Jul 23, 2026

Summary not yet generated.

Partner

Trade KN commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Apr 29, 2026 · Period ending Apr 28, 2026

Summary not yet generated.

10-Q Filed Apr 28, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed Apr 23, 2026 · Period ending Apr 23, 2026

Summary not yet generated.

10-K Filed Feb 9, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Feb 13, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B3 Filed Jun 30, 2015

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 28, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Earnings (Unaudited)

(in millions, except per share amounts)

Description Three Months Ended June 30, 2026 Three Months Ended June 30, 2025 Six Months Ended June 30, 2026 Six Months Ended June 30, 2025
Revenues 166.8 145.9 319.9 278.1
Cost of goods sold 92.1 81.7 178.0 160.1
Impairment charges 3.6 3.6
Restructuring charges - cost of goods sold 0.1 0.2 0.5
Gross profit 74.6 60.6 141.7 113.9
Research and development expenses 10.6 10.0 22.3 19.7
Selling and administrative expenses 39.2 35.9 78.6 73.1
Restructuring charges 0.1 0.2 2.4
Operating expenses 49.9 45.9 101.1 95.2
Operating earnings 24.7 14.7 40.6 18.7
Interest expense, net (1.7) (2.5) (3.2) (5.2)
Other expense, net (0.4) (0.9) (3.8) (1.4)
Earnings before income taxes and discontinued operations 22.6 11.3 33.6 12.1
Provision for income taxes 4.2 3.5 3.9 4.7
Earnings from continuing operations 18.4 7.8 29.7 7.4
Earnings (loss) from discontinued operations, net 1.0 (0.6) (1.6)
Net earnings 19.4 7.8 29.1 5.8
Earnings per share from continuing operations:
Basic 0.21 0.09 0.35 0.08
Diluted 0.21 0.09 0.34 0.08
Earnings (loss) per share from discontinued operations:
Basic 0.02 (0.01) (0.01)
Diluted 0.01 (0.01) (0.01)
Net earnings per share:
Basic 0.23 0.09 0.34 0.07
Diluted 0.22 0.09 0.33 0.07
Weighted-average common shares outstanding:
Basic 85.7 86.9 85.6 87.3
Diluted 87.9 87.6 87.9 88.3

Consolidated Balance Sheets (Unaudited)

(in millions, except share and per share amounts)

Description June 30, 2026 December 31, 2025
Current assets:
Cash and cash equivalents 49.6 54.2
Receivables, net of allowances of $0.3 and $0.0 116.5 102.8
Inventories 147.1 124.6
Prepaid and other current assets 11.1 9.8
Total current assets 324.3 291.4
Property, plant, and equipment, net 145.3 140.2
Goodwill 270.4 270.3
Intangible assets, net 133.1 141.1
Operating lease right-of-use assets 18.5 19.1
Investment in affiliate 83.4 83.4
Other assets and deferred charges 101.0 105.6
Total assets 1,076.0 1,051.1
Current liabilities:
Accounts payable 48.3 42.9
Accrued compensation and employee benefits 24.6 29.7
Operating lease liabilities 4.5 4.1
Other accrued expenses 22.0 28.2
Federal and other taxes on income 1.9 1.0
Total current liabilities 101.3 105.9
Long-term debt 131.0 114.0
Deferred income taxes 1.1 1.1
Long-term operating lease liabilities 14.7 16.1
Other liabilities 32.4 38.2
Commitments and contingencies (Note 14)
Stockholders' equity:
Preferred stock - $0.01 par value; 10,000,000 shares authorized; none issued
Common stock - $0.01 par value; 400,000,000 shares authorized; 100,867,089 and 85,410,326 shares issued and outstanding at June 30, 2026, respectively, and 99,651,892 and 84,887,498 shares issued and outstanding at December 31, 2025, respectively 1.0 1.0
Treasury stock - at cost; 15,456,763 and 14,764,394 shares at June 30, 2026 and December 31, 2025, respectively (293.2) (270.7)
Additional paid-in capital 1,747.2 1,739.6
Accumulated deficit (540.3) (569.4)
Accumulated other comprehensive loss (119.2) (124.7)
Total stockholders' equity 795.5 775.8
Total liabilities and stockholders' equity 1,076.0 1,051.1

Consolidated Statements of Cash Flows (Unaudited)

(in millions)

Description Six Months Ended June 30, 2026 Six Months Ended June 30, 2025
Operating Activities
Net earnings 29.1 5.8
Adjustments to reconcile net earnings to cash from operating activities:
Depreciation and amortization 18.9 18.1
Stock-based compensation 16.6 16.5
Deferred income taxes 5.6 4.8
Non-cash interest expense and amortization of debt issuance costs 0.3 2.8
Impairment charges on fixed assets 3.6
(Gain) loss on sale of business (0.8) 1.6
Other, net (6.5) (3.6)
Changes in assets and liabilities (excluding effects of foreign exchange):
Receivables, net (14.0) (2.8)
Inventories (23.3) (0.4)
Prepaid and other current assets (2.1) (1.7)
Accounts payable 5.8 (20.8)
Accrued compensation and employee benefits (5.1) (6.6)
Other accrued expenses (7.7) (5.4)
Accrued taxes 0.4 (0.9)
Other non-current assets and non-current liabilities (2.7) (13.9)
Net cash provided by operating activities 27.5 37.7
Investing Activities
Capital expenditures (17.3) (9.1)
Purchase of investments (1.6)
Proceeds from the sale of investments 1.6
Proceeds from seller loan repayment 0.5
Net cash used in investing activities (17.3) (8.6)
Financing Activities
Borrowings under revolving credit facility 105.0
Proceeds from exercise of stock options 5.8 0.6
Payments under revolving credit facility (88.0) (15.0)
Repurchase of common stock (22.5) (35.0)
Tax on restricted stock and performance share unit vesting and stock option exercises (14.8) (6.9)
Payments of finance lease obligations (0.2) (0.2)
Net cash used in financing activities (14.7) (56.5)
Effect of exchange rate changes on cash and cash equivalents (0.1) 0.5
Net decrease in cash and cash equivalents (4.6) (26.9)
Cash and cash equivalents at beginning of period 54.2 130.1
Cash and cash equivalents at end of period 49.6 103.2
Supplemental information - cash paid for:
Income taxes 5.2 6.1
Interest 4.0 4.2

Amounts as printed on the EDGAR/iXBRL face — (in millions, except per share amounts); (in millions, except share and per share amounts); (in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About Knowles Corp

Source: Item 1 (Business) from the 10-K filed February 9, 2026. Description as filed by the company with the SEC.

ITEM 1. BUSINESS

Unless the context otherwise requires, references in this Annual Report on Form 10-K to “Knowles,” the “Company,” “we,” “our,” or “us” refer to Knowles Corporation and its consolidated subsidiaries.

Our Company

We are a leading manufacturer of specialty electronic components. We design parts that perform unique, critical functions for innovative technologies. Through extreme reliability, custom engineering, and scalable manufacturing, our high-performance capacitors, radio frequency (“RF”) filters, advanced microphones, and balanced armature speakers enable and enhance the most demanding applications across medtech, defense, industrial, and electrification/energy markets with the power to change, improve, and save lives. Founded in 1946 and headquartered in Itasca, Illinois, Knowles has grown into a global organization with approximately 5,200 employees at facilities located in 11 countries around the world.

Our Strategy

The Company is focused on leveraging its unique technologies to design custom engineered solutions and then deliver them at scale for customers in high growth markets that value our solutions.

In our Precision Devices ("PD") segment, our high-performance capacitors and RF filtering solutions enable some of the most demanding applications in the defense, industrial, medtech, and electrification/energy markets. Our capacitor portfolio includes products with highly specialized requirements including high voltage, high temperature, and high reliability. We also deliver RF filtering solutions across a broad range of applications and frequencies primarily serving the defense market. We continue to focus on sales growth and improved margins by expanding our presence in profitable markets through organic initiatives and acquisitions.

Read full description ↓

In our Medtech & Specialty Audio ("MSA") segment, our primary focus is to deliver high reliability and industry leading balanced armature speakers and microphones to leading hearing health manufacturers and specialty audio markets. We work collaboratively with customers to ensure that our solutions meet their size, broad frequency response, and low power or custom acoustic module requirements. We continue to focus on sales growth and improved margins by leveraging our core strengths in manufacturing and research and development.

Our Business Segments

We have two reportable segments - Precision Devices ("PD") and MedTech & Specialty Audio ("MSA"). These segments were determined in accordance with Financial Accounting Standards Board Accounting Standards Codification 280 - Segment Reporting. The segments are aligned around similar product applications serving our key end markets to enhance focus on end market growth strategies.

Our reportable segments are as follows:

•PD Segment

Our PD segment specializes in the custom design and delivery of high performance capacitor products and RF solutions primarily serving the defense, industrial, medtech, and electrification/energy markets. PD has sales, support, and engineering facilities in North America, Europe, and Asia as well as manufacturing facilities in North America and Asia.

•MSA Segment

Our MSA segment designs and manufactures balanced armature speakers and microphones used in hearing health and specialty audio applications that serve the medtech and industrial markets. MSA has sales, support, and engineering facilities in North America, Europe, and Asia, as well as manufacturing facilities in Asia.

We sell our products directly to original equipment manufacturers ("OEMs") and through sales representatives and distributors worldwide.

Market Trends

In our PD segment, global conflict has given rise to increasing defense spending on electronic warfare, including an increasing array of new technologies to address rapidly evolving threats and adversaries. Many suppliers that provide technical, engineering, and manufacturing services for the defense sector are located in, or have facilities located in, countries that are viewed as potential strategic adversaries. As a result, there is a rising demand for supply partners throughout the value chain that can reliably and rapidly deliver custom solutions with strong domestic manufacturing footprints.

Within PD, the demand for high performance capacitors, including specialty film, is seeing potentially large growth as alternative technologies emerge to address the accelerating demand for power.

The trend toward domestic manufacturing footprints in the PD segment is amplified and extends across many of the markets we serve by the recent rise of trade barriers, including tariffs, as companies seek to mitigate the effect on their costs and the prices passed through to their customers.

In our MSA segment, as life expectancy rates increase and the aging population grows, the correlating health care expenditures are increasing. These demographic changes and the expansion of hearing health care access in emerging markets is expected to drive volume growth for hearing aids. In addition, recent U.S. government regulations have enabled people with mild hearing loss to buy hearing aids over-the-counter. This opens new channels for individuals in a demographic with extremely low hearing aid adoption, and may serve to reduce the stigma associated with hearing aids.

Competitive Landscape

Success in the specialty electronic components industry is primarily driven by innovation and customization. Our customers drive innovation and change, and with our strong intimacy of customer applications, we are able to produce solutions that are critical for the success and creation of their products. Another of our differentiators is our ability to customize at scale. Through our deep engineering expertise we are positioned to offer our customers uniquely customized components, rooted in the standards of exceptional quality and reliability. Key competitors of our PD segment include: Kyocera AVX, Yageo Corporation's Kemet products, Vishay Intertechnology, and a broad range of specialty companies and brands. Our MSA segment's primary competitor is Sonion.

In the PD segment, the end markets tend to have less pricing pressure. We see a fragmented set of competitors across high end capacitors and RF filters for a diverse set of end markets including defense, medtech, industrial, and electrification/energy.

In the MSA segment, our leading technology and our investments in research and development enable us to introduce new products focused on high reliability, size, broad frequency response, and low power. Our customers are adopting these high-value microphones and balanced armature speakers to improve the overall audio performance of their devices which in turn improves the end user experience. For products that were introduced in prior years, we strive to offset anticipated price erosion through bill of material cost reductions, productivity improvements, and equipment efficiency.

Customers, Sales, and Distribution

We serve customers in the medtech, defense, industrial, and electrification/energy markets. Our customers include some of the largest OEMs and operators in these markets. In addition, many of our OEM customers outsource to contract manufacturers.

We manufacture and develop our products as well as maintain sales and technical customer support offices in North America, Europe, and Asia. We supplement our direct sales force with external sales representatives and distributors. Our global distribution center is located in Penang, Malaysia. Our worldwide sales force provides geographically specific support to our customers and specialized selling of product lines to various customer bases.

The Company's customers that accounted for 10% or more of total revenues in 2025 were WS Audiology A/S and TTI, Inc. WS Audiology is a hearing aid manufacturer and TTI is a distributor of electromechanical components. They each represented the following percentages of total Company revenues:

Years Ended December 31,

2025 2024 2023

WS Audiology A/S 11 % 14 % 16 %

TTI Inc. 10 % * *

* Less than 10% of total revenues.

For further detail and for additional disclosures regarding sales and long-lived assets by geographic location, see Note 17. Segment Information to our Consolidated Financial Statements under Item 8, "Financial Statements and Supplementary Data."

Raw Materials

We use a wide variety of raw materials, primarily metals, ceramic powder, and semi-processed or finished components. Commodity pricing for various metals, such as palladium, gold, brass, stainless steel, and copper, fluctuates. As a result, our operating results are exposed to such fluctuations. Although some cost increases may be recovered through increased prices to customers, if commodity prices trend upward, we attempt to control such costs through fixed-price contracts with suppliers and various other programs.

We rely on highly specialized suppliers or foundries for critical materials, components, or subassemblies that are used in our products which, in some cases, may be sole sourced from such suppliers or foundries or, such suppliers or foundries may also be a strategic supplier to one of our competitors or a customer. The loss of any single supplier has not had a material impact on operating profits. However, should an event occur which affects the ability or willingness of any supplier or foundry to continue to deliver materials or components to us in a timely manner, we may not be able to identify or qualify an alternative supplier in a timely manner which, in any such period and future periods, could have a material adverse impact on our results of operations. See